Krsnaa Diagnostics Limited (KRSNAA) - Total Liabilities

Latest as of September 2025: Rs5.84 Billion INR ≈ $63.13 Million USD

Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has total liabilities worth Rs5.84 Billion INR (≈ $63.13 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Krsnaa Diagnostics Limited net asset momentum to track the company's year-over-year net asset growth rate.

Krsnaa Diagnostics Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Krsnaa Diagnostics Limited's total liabilities have evolved over time, based on quarterly financial data. See Krsnaa Diagnostics Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Krsnaa Diagnostics Limited Competitors by Total Liabilities

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their total liabilities.

Company Country Total Liabilities
AgriFORCE Growing Systems Ltd
NASDAQ:AGRI
USA $4.36 Million
Tah Hsin Industrial Corp
TW:1315
Taiwan NT$994.94 Million
LongDa Construction & Development Corp
TW:5519
Taiwan NT$8.56 Billion
Nexen Corporation
KO:005720
Korea ₩3.26 Trillion
Soluna Holdings Inc
NASDAQ:SLNH
USA $75.70 Million
Saniona AB
ST:SANION
Sweden Skr44.58 Million
Conduent Inc
NASDAQ:CNDT
USA $1.57 Billion
High Tide Inc
NASDAQ:HITI
USA $244.82 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Krsnaa Diagnostics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see KRSNAA market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.42 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.63 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.39 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Krsnaa Diagnostics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual total liabilities of Krsnaa Diagnostics Limited from 2017 to 2025.

Year Total Liabilities Change
2025-03-31 Rs3.99 Billion
≈ $43.13 Million
+10.14%
2024-03-31 Rs3.62 Billion
≈ $39.16 Million
+111.57%
2023-03-31 Rs1.71 Billion
≈ $18.51 Million
-17.49%
2022-03-31 Rs2.07 Billion
≈ $22.43 Million
-44.34%
2021-03-31 Rs3.73 Billion
≈ $40.30 Million
-54.94%
2020-03-31 Rs8.27 Billion
≈ $89.43 Million
+34.70%
2019-03-31 Rs6.14 Billion
≈ $66.39 Million
+93.54%
2018-03-31 Rs3.17 Billion
≈ $34.30 Million
+217.46%
2017-03-31 Rs999.19 Million
≈ $10.81 Million
--

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research
Market Cap
$193.77 Million
Rs17.92 Billion INR
Market Cap Rank
#16625 Global
#874 in India
Share Price
Rs552.35
Change (1 day)
+1.04%
52-Week Range
Rs520.30 - Rs867.05
All Time High
Rs1020.15
About

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more